Ensysce Biosciences (ENSC) Assets Average (2018 - 2025)

Ensysce Biosciences (ENSC) has reported Assets Average for 8 consecutive years, with $5.3 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Assets Average fell 29.04% year-over-year to $5.3 million in Q4 2025; TTM through Dec 2025 was $5.3 million, a 29.04% decrease from a year earlier, with the FY2025 full-year figure at $6.5 million, up 57.12% from the prior year.
• Assets Average was $5.3 million for Q4 2025 at Ensysce Biosciences, up from $4.4 million in the prior quarter.
• Over five years, Assets Average peaked at $14.4 million in Q1 2022 and troughed at $1.1 million in Q3 2021.
• A 5-year average of $6.1 million and a median of $5.2 million in 2023 frame the typical range for Assets Average.
• Across the five-year window, Assets Average plunged 94.83% in 2021 and soared 659.57% in 2022, its largest moves.
• Over 5 years, Assets Average stood at $8.7 million in 2021, then slipped by 18.94% to $7.1 million in 2022, then slumped by 58.19% to $3.0 million in 2023, then surged by 152.78% to $7.5 million in 2024, then retreated by 29.04% to $5.3 million in 2025.
• The last three Assets Average figures came in at $5.3 million (Q4 2025), $4.4 million (Q3 2025), and $5.1 million (Q2 2025), per Business Quant data.